Chromadex Corp Stock Market Value
| CDXC Stock | USD 7.44 0.19 2.49% |
| Symbol | Chromadex |
Chromadex Corp Price To Book Ratio
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chromadex Corp. If investors know Chromadex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chromadex Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.02 | Revenue Per Share 1.215 | Quarterly Revenue Growth 0.312 | Return On Assets 0.0051 | Return On Equity 0.0482 |
The market value of Chromadex Corp is measured differently than its book value, which is the value of Chromadex that is recorded on the company's balance sheet. Investors also form their own opinion of Chromadex Corp's value that differs from its market value or its book value, called intrinsic value, which is Chromadex Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chromadex Corp's market value can be influenced by many factors that don't directly affect Chromadex Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chromadex Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chromadex Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chromadex Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Chromadex Corp 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Chromadex Corp's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Chromadex Corp.
| 08/25/2024 |
| 11/23/2024 |
If you would invest 0.00 in Chromadex Corp on August 25, 2024 and sell it all today you would earn a total of 0.00 from holding Chromadex Corp or generate 0.0% return on investment in Chromadex Corp over 90 days. Chromadex Corp is related to or competes with Ikena Oncology, Eliem Therapeutics, HCW Biologics, Exicure, Century Therapeutics, Kezar Life, and Mineralys Therapeutics,. ChromaDex Corporation operates as a bioscience company focusing on healthy aging More
Chromadex Corp Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Chromadex Corp's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Chromadex Corp upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.64 | |||
| Information Ratio | 0.1561 | |||
| Maximum Drawdown | 73.19 | |||
| Value At Risk | (3.95) | |||
| Potential Upside | 6.69 |
Chromadex Corp Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Chromadex Corp's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Chromadex Corp's standard deviation. In reality, there are many statistical measures that can use Chromadex Corp historical prices to predict the future Chromadex Corp's volatility.| Risk Adjusted Performance | 0.1399 | |||
| Jensen Alpha | 1.13 | |||
| Total Risk Alpha | 0.1082 | |||
| Sortino Ratio | 0.5345 | |||
| Treynor Ratio | 0.4577 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Chromadex Corp's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Chromadex Corp Backtested Returns
Chromadex Corp is risky given 3 months investment horizon. Chromadex Corp secures Sharpe Ratio (or Efficiency) of 0.16, which signifies that the company had a 0.16% return per unit of risk over the last 3 months. We have analyzed and interpolated thirty different technical indicators, which can help you to evaluate if expected returns of 1.49% are justified by taking the suggested risk. Use Chromadex Corp Risk Adjusted Performance of 0.1399, downside deviation of 2.64, and Mean Deviation of 4.07 to evaluate company specific risk that cannot be diversified away. Chromadex Corp holds a performance score of 12 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 3.35, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Chromadex Corp will likely underperform. Use Chromadex Corp treynor ratio, kurtosis, period momentum indicator, as well as the relationship between the downside variance and day median price , to analyze future returns on Chromadex Corp.
Auto-correlation | 0.39 |
Below average predictability
Chromadex Corp has below average predictability. Overlapping area represents the amount of predictability between Chromadex Corp time series from 25th of August 2024 to 9th of October 2024 and 9th of October 2024 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Chromadex Corp price movement. The serial correlation of 0.39 indicates that just about 39.0% of current Chromadex Corp price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.39 | |
| Spearman Rank Test | 0.22 | |
| Residual Average | 0.0 | |
| Price Variance | 3.03 |
Chromadex Corp lagged returns against current returns
Autocorrelation, which is Chromadex Corp stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Chromadex Corp's stock expected returns. We can calculate the autocorrelation of Chromadex Corp returns to help us make a trade decision. For example, suppose you find that Chromadex Corp has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Chromadex Corp regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Chromadex Corp stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Chromadex Corp stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Chromadex Corp stock over time.
Current vs Lagged Prices |
| Timeline |
Chromadex Corp Lagged Returns
When evaluating Chromadex Corp's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Chromadex Corp stock have on its future price. Chromadex Corp autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Chromadex Corp autocorrelation shows the relationship between Chromadex Corp stock current value and its past values and can show if there is a momentum factor associated with investing in Chromadex Corp.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Chromadex Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Chromadex Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Chromadex Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Chromadex Corp Stock:Check out Chromadex Corp Correlation, Chromadex Corp Volatility and Chromadex Corp Alpha and Beta module to complement your research on Chromadex Corp. For information on how to trade Chromadex Stock refer to our How to Trade Chromadex Stock guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Chromadex Corp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.